Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

NCT00492999

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +16 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT04449874

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

NCT04521231

Conditions
B Cell Precursor Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of California San Francisco Fresno at Community Cancer Institute Clovis, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

NCT06246110

Conditions
NSCLC, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Southern Cancer Care Daphne, Alabama, United States
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • California Cancer Care Associates for Research & Excellence Fresno, California, United States
  • California Research Institute Los Angeles, California, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

NCT05396833

Conditions
Metastatic or Locally Advanced Unresectable Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • Augusta University - formerly Georgia Regents University Augusta, Georgia, United States
  • The University of Kansas Medical Center Research Institute, Inc. Kansas City, Kansas, United States
View all 22 locations
View Trial Details

Related conditions